Fundz

Vesper Bio Appoints Jacob Falck Hansen as Chief Executive Officer

PRIVATEJul 01, 2025

Position

Chief Executive Officer

Company

Vesper Bio

Jacob Falck Hansen
DenmarkBiotechnologyHealth Care

Description

Denmark-based Vesper Bio has announced the appointment of Jacob Falck Hansen as its Chief Executive Officer. With over 15 years of experience in the pharmaceutical and biotech industry, he is expected to lead the company's development efforts.

Quick answer

Vesper Bio Appoints Jacob Falck Hansen as Chief Executive Officer (July 1, 2025). Vesper Bio is based in Denmark.

Who is the new Chief Executive Officer at Vesper Bio?
Vesper Bio named Jacob Falck Hansen Chief Executive Officer, announced July 1, 2025.
What did Vesper Bio announce on July 1, 2025?
Denmark-based Vesper Bio has announced the appointment of Jacob Falck Hansen as its Chief Executive Officer. With over 15 years of experience in the pharmaceutical and biotech industry, he is expected to lead the company's development efforts.
What does Vesper Bio do?
Vesper Bio is a biotechnology company based in Denmark.
Where is Vesper Bio based?
Vesper Bio is based in Denmark.
Which similar companies made leadership changes around the same time?
Jade Biosciences (July 1, 2025), Lavior Pharma (July 1, 2025), ISOThrive (July 2, 2025) and bluebird bio (July 2, 2025) also announced leadership changes within 45 days of Vesper Bio.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Vesper Bio, and when

A new leader at Vesper Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Vesper Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vesper Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vesper Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vesper Bio

Location

Denmark

About

Vesper Bio is a biotechnology company based in Denmark. It focuses on developing innovative oral therapies for the treatment of frontotemporal dementia. The company is backed by significant investment from leading ventures in the biotech sector. Vesper Bio is committed to advancing healthcare solutions addressing neurodegenerative diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vesper Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Vesper Bio's next move

Learn about Strategic plan

Vesper Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.